Tachykinin receptor antagonists

Details for Australian Patent Application No. 2003224868 (hide)

Owner Eli Lilly and Company

Inventors Hembre, Erik James; Jungheim, Louis Nickolaus; Savin, Kenneth Allen; Remick, David Michael; Gardinier, Kevin Matthew; Hong, Jian Eric; Amegadzie, Albert Kudzovi; Muehl, Brian Stephen; Robertson, Michael Alan

Agent Spruson & Ferguson

Pub. Number AU-B-2003224868

PCT Number PCT/US03/10682

PCT Pub. Number WO2003/091227

Priority 60/376,121 26.04.02 US; 60/440,865 16.01.03 US

Filing date 22 April 2003

Wipo publication date 10 November 2003

Acceptance publication date 20 November 2008

International Classifications

C07D 249/06 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/497 (2006.01)

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/12 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 Drugs for disorders of the urinary system

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/376,121 26.04.02 US; 60/440,865 16.01.03 US

18 December 2003 Application Open to Public Inspection

  Published as AU-B-2003224868

20 November 2008 Application Accepted

  Published as AU-B-2003224868

27 November 2008 Corrigenda

  Applications Accepted - Name Index Under the name Eli Lilly and Company, Application No. 2003224868, under INID(72) delete the following co-inventors Remick, David Michael and Muehl, Brian Steven

19 March 2009 Standard Patent Sealed

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003224869-High foaming, grease cutting light duty liquid compositions containing at least one natural extract

2003224867-REMOTELY CONTROLLED WATER LINE SHUT OFF SYSTEM